Obesity is associated with an increased incidence and severity of asthma, as well as other
lung disorders, such as pulmonary hypertension. Adiponectin (APN), an antiinflammatory …

BACKGROUND: Epidemiologic data indicate an increased incidence of asthma in the
obese. OBJECTIVE: Because serum levels of the insulin-sensitizing and anti-inflammatory …

Remodeling of the pulmonary arteries is a common feature among the heterogeneous
disorders that cause pulmonary hypertension. In these disorders, the remodeled pulmonary …

Adiponectin (APN) is an adipocyte-derived factor that exists at high concentrations in serum
and has anti-inflammatory and systemic vascular-protective properties. In this study, we …

Adiponectin plays a role in asthma and obesity, but its effects and mechanism in obesity-
related asthma remain elusive. This study aimed to evaluate the effects of adiponectin on …

Asthma is a heterogeneous inflammatory airway disease, which exhibits multiple
phenotypes, mainly defined by a combination of different clinical features. Asthma …

Adipokines, factors produced by adipose tissue, may be proinflammatory (such as leptin and
resistin) or anti‐inflammatory (such as adiponectin). Effects of these adipokines on the lungs …

Adiponectin is a cytokine with both proinflammatory and anti-inflammatory properties that is
expressed in epithelial cells in the airway in chronic obstructive pulmonary disease …

Adiponectin is an adipose derived hormone that declines in obesity. We have previously
shown that exogenous administration of adiponectin reduces allergic airways responses in …

Purpose The relationship between asthma and obesity is well established, although the
pathophysiological mechanisms linking both diseases remain unknown. Adiponectin is a …